Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors

Gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) is known to overexpress somatostatin receptors (SSTRs), most commonly SSTR2 and SSTR5. The expression of SSTRs on tumor cells forms the basis for somatostatin analog treatment of patients with NEN. The present study detected the expression of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Wang, Yuhong, Wang, Wei, Jin, Kaizhou, Fang, Cheng, Lin, Yuan, Xue, Ling, Feng, Shiting, Zhou, Zhiwei, Shao, Chenghao, Chen, Minhu, Yu, Xianjun, Chen, Jie
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403486/
https://ncbi.nlm.nih.gov/pubmed/28454229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5591
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi